Prosecution Insights
Last updated: April 19, 2026
Application No. 18/074,180

VENTRICULAR ASSIST DEVICE HAVING PRESSURE SENSOR EMBEDDED DURABLE DISPLACEMENT BLOOD PUMP

Non-Final OA §112
Filed
Dec 02, 2022
Examiner
HOUGH, JESSANDRA F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
3R Life Sciences Corporation
OA Round
1 (Non-Final)
45%
Grant Probability
Moderate
1-2
OA Rounds
4y 2m
To Grant
82%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allow Rate
129 granted / 289 resolved
-25.4% vs TC avg
Strong +38% interview lift
Without
With
+37.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
42 currently pending
Career history
331
Total Applications
across all art units

Statute-Specific Performance

§101
8.4%
-31.6% vs TC avg
§103
50.0%
+10.0% vs TC avg
§102
16.9%
-23.1% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 289 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Embodiment B, Claims 1-2 and 5-19, in the reply filed on October 27, 2025 is acknowledged. Claims 3-4 and 20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on October 27, 2025. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-2 and 5-19 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 contains the limitation “…a proximal stem, and a distal stem, wherein the flexible membrane sac is attached with the proximal stem and the distal stem as a stress-relief suspension mechanism…” However, it is unclear how the proximal and distal stem function as a stress-relief suspension and the instant specification fails to detail how these function in order create a stress-relief suspension. The instant specification details in [0114] that the flexible sac membrane is suspended by stress-relief stems (e.g. proximal stem and distal stem) and [0178] details that the proximal stem and the distal stem as a stress-relief suspension mechanism. There fails to be adequate description to how the proximal and distal stem operate and function to create a stress-relief suspension mechanism. “An original claim may lack written description support when (1) the claim defines the invention in functional language specifying a desired result but the disclosure fails to sufficiently identify how the function is performed or the result is achieved or (2) a broad genus claim is presented but the disclosure only describes a narrow species with no evidence that the genus is contemplated. See Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1349-50 (Fed. Cir. 2010) (en banc). See MPEP 2163.03. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-2 and 5-19 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 contains the limitation “…a proximal stem, and a distal stem, wherein the flexible membrane sac is attached with the proximal stem and the distal stem as a stress-relief suspension mechanism…” However, it is unclear if the proximal and distal “stem” is a particular structure to create the “stress-relief suspension” or if merely a proximal and distal portion to “hold” the flexible membrane sac will inherently create this stress-relief suspension. Claim 20 recites the limitation "the trench" in line 1. There is insufficient antecedent basis for this limitation in the claim. It is unclear if this is the same “superficial trench” in claim 19 or a different trench. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Lu (US 2008/0300447 A1) discloses a dual pulsation bi-ventricular assist device wherein the blood pump (e.g. Fig 6) has an elastic membrane 205 that separates the blood into one sac/compartment 201 and the second compartment 202 holding a working fluid, but fails to have the stress-relief suspension mechanism, or a pressure sensing system. Steingraber (US 2022/01111962 A1) teaches a blood pump with a blood pressure sensor for measuring a present pressure in the diaphragm blood pump (e.g. [0052]) with a working chamber of the piston pump to utilize a pressure line and air chamber (e.g. [0054]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSANDRA F HOUGH whose telephone number is (571)270-7902. The examiner can normally be reached Monday-Thursday 7 am - 4 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Jessandra Hough March 12, 2026 /J.F.H./Examiner, Art Unit 3796 /William J Levicky/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Dec 02, 2022
Application Filed
Mar 18, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551710
STIMULATION APPARATUS
2y 5m to grant Granted Feb 17, 2026
Patent 12551716
PHOTOTHERAPY DEVICES FOR TREATMENT OF DERMATOLOGICAL DISORDERS OF THE SCALP
2y 5m to grant Granted Feb 17, 2026
Patent 12544133
APPARATUS AND METHOD FOR COLD PLASMA SKIN RESURFACING
2y 5m to grant Granted Feb 10, 2026
Patent 12514456
SYSTEM AND METHODS FOR LESION CHARACTERIZATION IN BLOOD VESSELS
2y 5m to grant Granted Jan 06, 2026
Patent 12453482
CONTINUOUS MONITORING OF A USER'S HEALTH WITH A MOBILE DEVICE
2y 5m to grant Granted Oct 28, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
45%
Grant Probability
82%
With Interview (+37.7%)
4y 2m
Median Time to Grant
Low
PTA Risk
Based on 289 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month